These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11701767)

  • 1. Characterization of a glycine receptor domain that controls the binding and gating mechanisms of the beta-amino acid agonist, taurine.
    Han NL; Haddrill JL; Lynch JW
    J Neurochem; 2001 Nov; 79(3):636-47. PubMed ID: 11701767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of taurine- and glycine-induced conformational changes in the M2-M3 domain of the glycine receptor.
    Han NL; Clements JD; Lynch JW
    J Biol Chem; 2004 May; 279(19):19559-65. PubMed ID: 14981077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of two mutations, M287L and Q266I, in the α1 glycine receptor subunit that modify sensitivity to alcohols.
    Borghese CM; Blednov YA; Quan Y; Iyer SV; Xiong W; Mihic SJ; Zhang L; Lovinger DM; Trudell JR; Homanics GE; Harris RA
    J Pharmacol Exp Ther; 2012 Feb; 340(2):304-16. PubMed ID: 22037201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The surface accessibility of the glycine receptor M2-M3 loop is increased in the channel open state.
    Lynch JW; Han NL; Haddrill J; Pierce KD; Schofield PR
    J Neurosci; 2001 Apr; 21(8):2589-99. PubMed ID: 11306612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of glycine receptor subunit creates beta-alanine receptor responsive to GABA.
    Schmieden V; Kuhse J; Betz H
    Science; 1993 Oct; 262(5131):256-8. PubMed ID: 8211147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of a putative intersubunit electrostatic bond enhances agonist efficacy at the human α1 glycine receptor.
    Welsh BT; Todorovic J; Kirson D; Allen HM; Bayly MD; Mihic SJ
    Brain Res; 2017 Feb; 1657():148-155. PubMed ID: 27923639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single beta subunit M2 domain residue controls the picrotoxin sensitivity of alphabeta heteromeric glycine receptor chloride channels.
    Shan Q; Haddrill JL; Lynch JW
    J Neurochem; 2001 Feb; 76(4):1109-20. PubMed ID: 11181831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Channel gating of the glycine receptor changes accessibility to residues implicated in receptor potentiation by alcohols and anesthetics.
    Lobo IA; Mascia MP; Trudell JR; Harris RA
    J Biol Chem; 2004 Aug; 279(32):33919-27. PubMed ID: 15169788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic and mutational analysis of Zn2+ modulation of recombinant human inhibitory glycine receptors.
    Laube B; Kuhse J; Betz H
    J Physiol; 2000 Jan; 522 Pt 2(Pt 2):215-30. PubMed ID: 10639099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human alpha1 and alpha2 homomeric glycine receptors by taurine and GABA.
    De Saint Jan D; David-Watine B; Korn H; Bregestovski P
    J Physiol; 2001 Sep; 535(Pt 3):741-55. PubMed ID: 11559772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles for loop 2 residues of alpha1 glycine receptors in agonist activation.
    Crawford DK; Perkins DI; Trudell JR; Bertaccini EJ; Davies DL; Alkana RL
    J Biol Chem; 2008 Oct; 283(41):27698-27706. PubMed ID: 18658152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The startle disease mutation Q266H, in the second transmembrane domain of the human glycine receptor, impairs channel gating.
    Moorhouse AJ; Jacques P; Barry PH; Schofield PR
    Mol Pharmacol; 1999 Feb; 55(2):386-95. PubMed ID: 9927632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc potentiation of the glycine receptor chloride channel is mediated by allosteric pathways.
    Lynch JW; Jacques P; Pierce KD; Schofield PR
    J Neurochem; 1998 Nov; 71(5):2159-68. PubMed ID: 9798943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Need rods? Get glycine receptors and taurine.
    Rentería RC; Johnson J; Copenhagen DR
    Neuron; 2004 Mar; 41(6):839-41. PubMed ID: 15046714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of charged residues in coupling ligand binding and channel activation in the extracellular domain of the glycine receptor.
    Absalom NL; Lewis TM; Kaplan W; Pierce KD; Schofield PR
    J Biol Chem; 2003 Dec; 278(50):50151-7. PubMed ID: 14525990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly conserved aspartic acid residue in the signature disulfide loop of the alpha 1 subunit is a determinant of gating in the glycine receptor.
    Schofield CM; Jenkins A; Harrison NL
    J Biol Chem; 2003 Sep; 278(36):34079-83. PubMed ID: 12826676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational changes in extracellular loop 2 associated with signal transduction in the glycine receptor.
    Cederholm JM; Absalom NL; Sugiharto S; Griffith R; Schofield PR; Lewis TM
    J Neurochem; 2010 Dec; 115(5):1245-55. PubMed ID: 20874766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The M4 transmembrane segment contributes to agonist efficacy differences between alpha1 and alpha3 glycine receptors.
    Chen X; Webb TI; Lynch JW
    Mol Membr Biol; 2009 Aug; 26(5):321-32. PubMed ID: 19626554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist pharmacology of neonatal and adult glycine receptor alpha subunits: identification of amino acid residues involved in taurine activation.
    Schmieden V; Kuhse J; Betz H
    EMBO J; 1992 Jun; 11(6):2025-32. PubMed ID: 1376243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel domain of the inhibitory glycine receptor determining antagonist efficacies: further evidence for partial agonism resulting from self-inhibition.
    Schmieden V; Kuhse J; Betz H
    Mol Pharmacol; 1999 Sep; 56(3):464-72. PubMed ID: 10462533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.